RaymondLBenzaMDFACC, FAHA, FCCP

Cardiology • New York, NY

Heart Failure & Transplantation

Professor of Medicine Chief Medical Officer PHope

Join to view full profile

Dr. Benza is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Benza's full profile

Already have an account?

Office
1 Gustave Levy Place Box 103
Hess building
New York, NY 10029
Phone+1 412-304-8866

Fax+1 212-824-8918
Is this information wrong?

Summary

Professor and System Director for Pulmonary Vascular Diseases at the Icahn School of Medicine at Mount Sinai. He is a Fellow of the AHA and ACC. He holds positions in the PVRI, ISHLT and served on President Barack Obama’s Committee on Organ Transplantation. He was knighted in 2015 for his philanthropic work. Dr. Benza is a Clinical Trialist and funded investigator for the NHLBI and the AHA.

Education & Training

University of Alabama Medical CenterChief Residency, Cardiovascular Disease, 1996 - 1997
University of Alabama Medical CenterFellowship, Cardiovascular Disease, 1993 - 1996
University of Michigan Health SystemResidency, Internal Medicine, 1990 - 1992
University of Michigan Health SystemInternship, Internal Medicine, 1989 - 1990
University of Florida College of MedicineClass of 1989

Certifications & Licensure

NY State Medical License 1992 - 2025
OH State Medical License 2020 - 2024
PA State Medical License 2008 - 2021
AL State Medical License Active through 2008
MI State Medical License 1991 - 1995
American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology

Awards, Honors, & Recognition

Association of University Cardiologists 2021
Bob and Corrine Endowed Chair of Heart Failure The Ohio State University, 2020
Best Doctors Pittsburgh 2013-2020
Pittsburgh Health Care Hero Pittsburgh Business Times, 2015, 2019
Fellow american college of chest physicians, 2015
Regional Top Doctor Castle Connolly, 2013-2015
Physician of the Year Pulmonary Hypertension Association, 2012
CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012-2013
Knight, Order of Maurice and Lasarus Royal Order of Savoy, Savoy Italy, 2011
James Magovern Chair for Cardiovascular Research Allegheny Singer Research Institute, 2008
Fellow American Heart Association
Fellow (FACC) American College of Cardiology
Join now to see all

Clinical Trials

REVEAL Registry™: Registry to Evaluate Early And Long-term PAH Disease Management Start of enrollment: 2006 Mar 01
Completed
Safety and Efficacy Study of Ambrisentan in Subjects With Pulmonary Hypertension Start of enrollment: 2006 Aug 01
Completed
Phase 3
Pharmacogenomics in Pulmonary Arterial Hypertension Start of enrollment: 2005 Jul 01
Withdrawn
Effects of Remote Patient Monitoring on Heart Failure Management Start of enrollment: 2009 Mar 01
Completed
Not Applicable
Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl. Start of enrollment: 2011 Mar 01
Completed
Phase 2
Study of Incidence of Respiratory Tract AEs in Patients Treated With Tyvaso® Compared to Other FDA Approved PAH Therapies Start of enrollment: 2010 Dec 01
Completed
Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH) Start of enrollment: 2012 Apr 01
Completed
Phase 2
Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction Start of enrollment: 2014 Jul 01
Completed
Phase 2
Effect of iNO on Invasively Derived Pulmonary Pressures in Patients With PAH Start of enrollment: 2016 Apr 01
Completed
Phase 2
A Study to Assess the Safety, Tolerability, and Hemodynamic Response of PB1046 in Subjects With PAH Start of enrollment: 2017 Oct 20
Completed
Phase 1
Telemonitoring to Treat Group 2 Pulmonary Hypertension Start of enrollment: 2023 Apr 01
Withdrawn
Phase 2
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Comparison Between REVEAL Lite 2 and COMPERA 2.0 for Risk Stratification in Pulmonary Arterial Hypertension.
Sandeep Sahay, Nelson Villasmil Hernandez, Fredrick Wang, Matthew Wooten, Duc T Nguyen, Charles Fauvel, Raymond Benza, Edward A Graviss> ;Chest. 2024 Mar 4
Risk scores as a surrogate in pulmonary arterial hypertension: a different lens.
R James White, Daniel J Lachant, Raymond L Benza> ;The Lancet. Respiratory Medicine. 2024 Mar 1
The nitric oxide-soluble guanylate cyclase-cGMP pathway in pulmonary hypertension: from PDE5 to soluble guanylate cyclase.
Ekkehard Grünig, Peter Sandner, Johannes-Peter Stasch, Gérald Simonneau, Raymond L Benza> ;European Respiratory Review. 2024 Jan 31
Prognostic value of deep echocardiographic phenotyping in pulmonary arterial hypertension.
Ghio, S., Badagliacca, R., Acquaro, M., Filomena, D., Recchioni, T., Papa, S., Colombo, D., Ditali, V., Carrozzi, C., Greco, A., Turco, A., Breviario, F., Vizza, D., S...> ;ERJ Open Research. 2024 Jan 1
CS1, a controlled-release formulation of valproic acid, for the treatment of patients with pulmonary arterial hypertension: Rationale and design of a Phase 2 clinical ...
Adamson, P., Bhatt, D., Frick, F., Olsson, G., Bergh, N., Dahlöf, B., Benza, R.> ;Pulmonary Circulation. 2024 Jan 1
The Role of Palliative Care in Heart Failure, Part 1: Referring Provider Perspectives About Opportunities in Advanced Cardiac Therapies.
Todd A Barrett, Sarah R MacEwan, Halia L Melnyk, Jaclyn Volney, Jonathan Singer, Gennaro Di Tosto, Laura J Rush, Karen Shiu-Yee, Raymond Benza, Ann Scheck McAlearney> ;Journal of Palliative Medicine. 2023 Dec 1
The Role of Palliative Care in Heart Failure, Part 4: A Framework for Collaboration in Advance Care Planning.
Todd A Barrett, Sarah R MacEwan, Jaclyn Volney, Jonathan Singer, Gennaro Di Tosto, Halia L Melnyk, Karen Shiu-Yee, Laura J Rush, Raymond Benza, Ann Scheck McAlearney> ;Journal of Palliative Medicine. 2023 Dec 1
The Role of Palliative Care in Heart Failure, Part 3: Facilitators and Barriers to Cardiac Palliative Care Clinic Development.
Todd A Barrett, Sarah R MacEwan, Halia Melnyk, Gennaro Di Tosto, Laura J Rush, Karen Shiu-Yee, Jaclyn Volney, Jonathan Singer, Raymond Benza, Ann Scheck McAlearney> ;Journal of Palliative Medicine. 2023 Dec 1
Real-world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research I...
Morland, K., Gerges, C., Elwing, J., Visovatti, S., Weatherald, J., Gillmeyer, K., Sahay, S., Mathai, S., Boucly, A., Williams, P., Harikrishnan, S., Minty, E., Hobohm...> ;Pulmonary Circulation. 2023 Oct 1
Risk Stratification in Pulmonary Arterial Hypertension: Perhaps Simple Is Not Best?
Charles Fauvel, R James White, Rebecca R Vanderpool, Roberto Badagliacca, Tobore Tobore, Mohammad Rahman, Carmine Dario Vizza, Shili Lin, Allen D Everett, Scott H Viso...> ;Chest. 2024 Feb 1
1 citations
Do Patients With Low-Risk Pulmonary Arterial Hypertension Really Benefit From Upfront Combination Therapy?: Insight From the AMBITION Trial.
Charles Fauvel, Yongqi Liu, Priscilla Correa-Jaque, Manreet K Kanwar, Carmine Dario Vizza, Shili Lin, Raymond L Benza> ;Chest. 2023 Dec 1
The heart of the matter: Right heart imaging indicators for treatment escalation in pulmonary arterial hypertension.
Paul Forfia, Raymond Benza, Michele D'Alto, Teresa De Marco, Jean M Elwing, Robert Frantz, Francois Haddad, Ronald Oudiz, Ioana R Preston, Stephan Rosenkranz, John Rya...> ;Pulmonary Circulation. 2023 Apr 1
1 citations
Treatment effects of pulmonary artery denervation for pulmonary arterial hypertension stratified by REVEAL risk score: Results from PADN-CFDA trial.
Juan Zhang, Jing Kan, Yongyue Wei, Caojin Zhang, Zhenwen Yang, Heping Gu, Fenling Fan, Hong Gu, Qiguang Wang, Dujiang Xie, Gangcheng Zhang, Xiaomei Guo, Yuehui Yin, Bo...> ;The Journal of Heart and Lung Transplantation. 2023 Aug 1
3 citations
European Society of Cardiology quality indicators for the care and outcomes of adults with pulmonary arterial hypertension. Developed in collaboration with the Heart F...
Suleman Aktaa, Chris P Gale, Margarita Brida, George Giannakoulas, Gabor Kovacs, Yochai Adir, Raymond L Benza, Michael Böhm, Andrew Coats, Michele D'Alto, Pilar Escrib...> ;European Journal of Heart Failure. 2023 Apr 1
5 citations
Smoking history and pulmonary arterial hypertension: Demographics, onset, and outcomes.
Adaani E Frost, Carol Zhao, Harrison W Farber, Raymond Benza, Joseph Yen, Mona Selej, C Gregory Elliott> ;The Journal of Heart and Lung Transplantation. 2023 Mar 1
6 citations
Pulmonary artery compliance in different forms of pulmonary hypertension.
Amber McCormick, Amita Krishnan, David Badesch, Raymond L Benza, Todd M Bull, Teresa De Marco, Jeremy Feldman, Anna R Hemnes, Russel Hirsch, Evelyn Horn, Jaime Kennedy...> ;Heart. 2023 Jun 26
4 citations
Derivation of a Risk Score (REVEAL-ECHO) Based on Echocardiographic Parameters of Patients With Pulmonary Arterial Hypertension.
Karim El-Kersh, Carol Zhao, Gregory Elliott, Harrison W Farber, Mardi Gomberg-Maitland, Mona Selej, Josephine Garcia-Ferrer, Raymond Benza> ;Chest. 2023 May 1
5 citations
Riociguat and the right ventricle in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
Raymond L Benza, David Langleben, Anna R Hemnes, Anton Vonk Noordegraaf, Stephan Rosenkranz, Thenappan Thenappan, Paul M Hassoun, Ioana R Preston, Stefano Ghio, Robert...> ;European Respiratory Review. 2022 Dec 31
3 citations
Safety and efficacy of RT234 vardenafil inhalation powder on exercise parameters in pulmonary arterial hypertension: phase II, dose-escalation study design.
Raymond L Benza, Veronica Franco, Mandar A Aras, Leslie Spikes, Daniel Grinnan, Carol Satler> ;Respiratory Research. 2022 Dec 17
1 citations
Prognostic role of pulmonary hemodynamics before transcatheter aortic valve replacement among patients with severe aortic stenosis.
Garima Dahiya, Andreas Kyvernitakis, Adee Elhamdani, Andrew Begg, Mark Doyle, Mahmoud Elsayed, Stephen Bailey, Amresh Raina, Manreet Kanwar, Robert W W Biederman, Raym...> ;The Journal of Heart and Lung Transplantation. 2023 Feb 1
Phenotypes of idiopathic pulmonary arterial hypertension.
Roberto Badagliacca, Raymond L Benza, Giovanna Manzi, Khodr Tello, Robert Naeije> ;The Lancet. Respiratory Medicine. 2022 Oct 1
10 citations
ISHLT consensus statement: Perioperative management of patients with pulmonary hypertension and right heart failure undergoing surgery.
Dana P McGlothlin, John Granton, Walter Klepetko, Maurice Beghetti, Erika B Rosenzweig, Paul A Corris, Evelyn Horn, Manreet K Kanwar, Karen McRae, Antonio Roman, Ryan ...> ;The Journal of Heart and Lung Transplantation. 2022 Sep 1
6 citations
Plasma Cell-Free DNA Predicts Survival and Maps Specific Sources of Injury in Pulmonary Arterial Hypertension.
Samuel B Brusca, Jason M Elinoff, Yvette Zou, Moon Kyoo Jang, Hyesik Kong, Cumhur Y Demirkale, Junfeng Sun, Fayaz Seifuddin, Mehdi Pirooznia, Hannah A Valantine, Carl ...> ;Circulation. 2022 Oct 4
7 citations
Contemporary risk scores predict clinical worsening in pulmonary arterial hypertension - An analysis of FREEDOM-EV.
Raymond L Benza, Mardi Gomberg-Maitland, Harrison W Farber, Carmine Dario Vizza, Meredith Broderick, Louis Holdstock, Andrew C Nelsen, Chunqin Deng, Youlan Rao, R Jame...> ;The Journal of Heart and Lung Transplantation. 2022 Nov 1
2 citations
INSPIRE: Safety and tolerability of inhaled Yutrepia (treprostinil) in pulmonary arterial hypertension (PAH).
Nicholas S Hill, Jeremy P Feldman, Sandeep Sahay, Raymond L Benza, Ioana R Preston, David Badesch, Robert P Frantz, Savan Patel, Ashley Galloway, Todd M Bull> ;Pulmonary Circulation. 2022 Jul 1
Join now to see all

Journal Articles

Clinical Research A Bayesian Model to Predict Survival After Left Ventricular Assist Device Implantation
Stephen H Bailey, Srinivas Murali, Joseph G Rogers, Raymond Benza, Jeffrey J Teuteberg, Colleen K McIlvennan, Robert L Kormos, JoAnn Lindenfeld, ScienceDirect

Lectures

Highlighted Original Research: Pulmonary Hypertension and Venous Thrombo-Embolic Disease and the Year in Review
2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019

Press Mentions

OSU Wexner Launches 'Hospital-at-Home' Program for Patients with Heart FailureJanuary 28th, 2022
WellSky® to Deliver in-Home Protocols for Patients with Heart FailureJanuary 27th, 2022
United Therapeutics Details New Data Presented at CHEST Annual Meeting 2021October 21st, 2021
Join now to see all

Grant Support

VITA: Vascular Interventions/Innovations and Therapeutic AdvancesNational Heart, Lung and Blood Institute2014–Present
Salivary Gland-Based Gene Therapy for Pulmonary Arterial HypertensionNational Heart, Lung and Blood Institute2013–Present
Pulmonary Hypertension Breakthrough InitiativeAmerican Heart Association2008–Present
Pharmacogenomics In Pulmonary Arterial HypertensionNational Heart, Lung, And Blood Institute2008
Pharmacogenomics In Pulmonary Arterial HypertensionNational Heart, Lung, And Blood Institute2005–2007
Genetic Determination Of Allograft VasculopathyNational Heart, Lung, And Blood Institute1998–2002